IONETIX

Ionetix is engaged in the development, manufacturing, and distribution of a novel class of superconducting cyclotrons for the point-of-care production of PET radioisotopes. With their significantly smaller size, lighter weight, lower power requirement, and lower price point, these systems offer significant advantages over conventional-design cyclotron technology. The company installs, operates, and manages cyclotrons producing the necessary doses of Ammonia N-13 at or near the imaging suite. Ionetix was founded in 2010 and is headquartered in